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Endocrine and Anatomical Correlations in
Human Ovarian Pathology
by A. F. Haney*
Knowledge of normal gonadal hormone production and function provides the basis for understanding
the ovarian pathologic effects resulting from perturbations in endocrine balance and feedback. A precisely
timed, complex, and well-coordinated cascade of ovarian steroidogenesis accompanies normal cyclical
follicularfunction. This cascade involves bothestrogens andandrogens. Alterations inthehormonal milieu
are associated with specific morphological changes in the ovary. While predictable hormonal changes
accompany commencement of menopause, several disease states are associated with ovarian dysfunction.
These diseases include polycystic ovarian syndrome and hyperthecosis, both associated with androgeni-
zation. Ovarian tumors may also be associated with morphological and clinical alterations. While endo-
crinologically inert ovarian tumors are associated with morphologic evidence of stromal activation, en-
docrinologically active ovarian tumors may cause differentiation along either male or female lines as a
consequence of differential productions of androgens and estrogens.
Introduction
Reproduction is a complex process involving inter-
action of the hypothalamus, pituitary, ovary, and the
lower genital tract. The cyclic pattern of sex steroid
production by the ovary is dramatically different from
that of the testis. Testicular hormone production is in-
dependent ofgerm cells and remains relatively constant
over the life-span of the individual, with only a slight
decline beyond the sixth decade oflife. By contrast, the
reproductive cycle in women is critically dependent on
the presence of ovarian follicles. As the number of oo-
cytes in the ovary is fixed during embryonic life, a de-
cline in ovarian function, termed the climacteric, is ob-
served over a relatively short interval at the end ofthe
reproductive life-span. While certainly not all ovarian
pathology is associated with alterations in ovarian func-
tion, aberrations of the menstrual cycle and abnormal
bleeding after menopause represent important clinical
clues to the presence of ovarian pathology. Conse-
quently, a thorough understanding ofthe physiology of
gonadal hormone production is helpful in understanding
ovarian pathology.
Gamete Physiology
Oocytes can only remain viable within the human
ovarywhenthey are enclosedby acomplicated arrange-
ment ofsupporting cells that are collectively termed the
follicle. The follicle is composed of avascular granulosa
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cell layers in direct contact with the oocyte, abasement
membrane surrounding the granulosa cells, and a vas-
cularized thecal compartment. Afunctional relationship
between the follicle and the surroundingovarian stroma
has never been proven, but the theca is thought to dif-
ferentiate from the stroma. Table 1 depicts the fate of
the follicles throughout a woman's life.
Germ cells migrate from the yolk sac into the prim-
itive gonad inthe first severalmonths ofembryoniclife.
Table 1. The complement of ovarian follicles throughout life.
Theoretical rate
Physiologic state offollicular
Age No. of oocytes ofthe follicles atresia
Week 20 ofges- 5-7 x 106 Primordial folli-
tation cle organiza-
tion
Weeks 20 to 40 Inactive primor- 29,000-43,000/
ofgestation dial follicles day
Birth 1-2 x 10' Inactive primor-
dial follicles
Childhood Inactive primor- 20-125/day
dial follicles
Puberty 3-4 x 105 Disorderly fol-
licular matur-
ation
Reproductive - Preovulatory 8/day
years follicles and
corpora lutea
Climacteric 1 x 104 Disorderly fol-
licular matur-
ation
Ovarian senes- Negligible Inactive follicles
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By 20 weeks gestation, they have actively undergone
mitosis and nowtotal 5to 7million oocytes. The oogonia
are rapidly incorporated into primitive follicles and are
arrested in the prophase of the first meiotic division.
At birth, there remain approximately 1 to 2 million fol-
licles, indicating a high rate of atresia in these early
primordial follicles. The cause for these early follicular
losses is unknown.
Rapid atresia continues throughout childhood, and at
puberty only 300,000 to 400,000 follicles remain. The
increasing gonadotropin levels at puberty result in or-
derly follicular maturation and ovulation. By the end of
the sixth decade of life, an occasional follicle remains,
and the decline in ovarian hormone production, termed
the climacteric, heralds the loss ofreproductive poten-
tial. As only 300 to 400 oocytes are lost by the process
of ovulation, the overwhelming majority of human oo-
cytes are lost prior to full differentiation. As the lowest
rate of atresia occurs during the reproductive years
when levels ofsex steroids and gonadotropins are high,
the hormonal balance likely has a significant influence
on the maintenance of these follicular structures.
Throughout history, the mean life expectancy of
women has dramatically increased from 25 years to 80
years. Thus, living into the climacteric and beyond is a
relatively new phenomenon for our species. The impact
ofa longer life-span is reflected in what constitutes the
most common causes of death. Several hundred years
ago, the most common causes ofdeath for women were
infectious diseases and childbirth; cardiovascular dis-
ease and neoplasia are now the most common modes of
death for women.
Gonadal Steroid Production
Ovarian hormone production to the levels observed
duringthereproductive years is dependent onthe pres-
ence ofoocytes. The follicular cells not only protect the
oocyte from undergoing degeneration, but also possess
gonadotropin receptors. These receptors couple follic-
ular development to hypothalamic/pituitary function
and actively synthesize steroids and other protein hor-
mones. The oocyte itselfdoes not possess gonadotropin
receptors nor does it synthesize significant quantities
of steroids.
Prior to puberty, the primordial oocytes are enclosed
by a single layer ofprimitive granulosa cells without an
identifiable thecal layer. During the onset of puberty,
the hypothalamus is desensitized to the suppressive ef-
fect ofcirculating steroids, causing gonadotropin levels
to rise, initiating follicular development. This in turn
stimulatesgonadalhornoneproduction, resultinginthe
well-known physical and psychological changes atten-
dant to sexual maturity.
Based onmorphologic criteria, ittakes approximately
65 days for primordial follicles to attain preovulatory
status, with all but the last 14 to 16 days independent
of gonadotropins. The general endocrinologic milieu is
important for early follicular maturation, however, pro-
viding a favorable environment for granulosa cell mi-
tosis and thecal differentiation (Fig. 1). This continuous
gonadotropin-independent differentiation setsthe stage
so that at any point in time, a cohort offollicles reaches
the critical stage where exposure to gonadotropins may
continue preovulatory development. Ifsufficientgonad-
otropins are not present during this critical interval,
the follicles uniformly undergo atresia (Plate 1). In clin-
ical terms, excision of the dominant cyclic structure,
i.e., either a preovulatory follicle or corpus luteum, in-
itiates recruitment ofa new cohort offollicles with ovu-
lation occurring 14 days later. The follicular events un-
der these circumstances are indistinguishable from
those ofthe normal follicular phase.
With the functional decline of the corpus luteum at
the end of the luteal phase, there is a reduction in the
negative feedback effect ofgonadal steroids, increasing
the levels of the circulating gonadotropins, primarily
follicle-stimulating hormone (FSH). As a consequence,
another cohort of follicles reaching that critical gonad-
otropin-dependent stage is recruited for the next cycle.
FSH appears to be the key gonadotropin at this stage
by virtue of its ability to induce aromatase activity in
granulosa cells. Attainment ofthe ability to respond to
FSH, i.e., the presence offunctional FSH receptors, is
probably the key event in that process. With an en-
hanced aromatase system, the granulosa cells produce
large quantities of estradiol from thecally derived pre-
cursors and undergo active mitosis, the two principal
characteristics of healthy follicles.
Ashumans areamonotocous species, follicle selection
is necessary so that only a single follicle reaches preo-
vulatory status each cycle. The process by which the
other competing follicles are retarded in their matura-
tion is unclear, but likely involves inhibition or loss of
FSH responsiveness. Little is known of the dynamics
offollicular steroidogenesis prior to follicle selection, as
the quantity of steroids produced by all the compart-
ments at that stage is small. In healthy follicles, the
estrogen/androgen ratio is high, whereas androgen pre-
dominates in the follicular fluid of atretic follicles. This
is consistent with the concept of FSH-induced aroma-
tase activity being the critical step in avoiding the oth-
erwise inevitable atresia.
The selection of a single dominant follicle culminates
inhighpreovulatoryestradiollevels. EstrogenandFSH
synergize to induce luteinizing hormone (LH) receptors
in the granulosa cells, preparing the follicle to respond
to the mid-cycle surge ofgonadotropins. LH is released
inthelargestamounts duringthe mid-cycle surge, caus-
ing a decline in aromatization and an increase in pro-
gesterone synthesis. This is obviously a well-coordi-
nated event, optimizing the hormonal milieu for early
embryonic events.
In understanding follicular steroidogenesis, it is im-
portant to divide the follicle into its basic components,
the avascular granulosa compartment, the theca, and
the ovarian stroma. Both the theca and ovarian stroma
possess all the steroidogenic enzymes necessary to pro-
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FIGURE 1. Compartmental follicular steroidogenesis.
duce the three classes of sex steroids in women: andro-
gens, estrogens, and progesterone. Despite the highest
FSH-inducible aromatase activity, the granulosa cells
lack the 17-20 desmolase enzyme required to reduce C-
21 progestogensto C-19androgens (Fig. 1). As follicular
fluid contains estrogen levels 1000-fold higher than
those observed in peripheral serum, it is likely that
androgens from the theca provide the substrate for
granulosa cell aromatization. As the granulosa com-
partment is avascular, it is likely that granulosa cell
estrogen production is predominantly responsible for
the high follicular fluid estrogen levels, whereas the
vascularized stroma and theca produce estrogens and
androgens primarily for the systemic circulation (Plate
2).
The steroidogenically active cells in the theca do not
bind FSH but are rich in LH receptors. LH stimulation
of the theca increases production of all classes of sex
steroids, but androgens are by far the greatest quan-
titatively in the form ofandrostenedione and, to a lesser
extent, testosterone. While the stromal compartment
is also steroidogenically active, the quantity of hor-
Estradiol
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mones produced is insignificant relative to the other
follicular compartments.
With the onset of the LH surge, both the granulosa
and thecal cells undergo amorphologic luteinization and
form the corpus luteum (Plate 3). Simultaneously, aro-
matization of thecally derived androgens to estrogens
by granulosa cells is dramatically reduced. While es-
trogens and androgens are still produced by thecal and
stromal cells throughout the luteal phase, the quantity
of progesterone produced by the granulosa cells is by
far greater, dominating luteal steroidogenesis (Fig. 2).
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In nonconceptive cycles, the estrogen and progester-
one production begins to decline midway through the
luteal phase. The mechanism ofluteolysis in humans is
unknown. In conceptive cycles, the fetal signal, human
chorionic gonadotropin (hCG), maintains the corpus lu-
teum and supports luteal progesterone production
through the early part of pregnancy. The fetal hCG
binds to the same receptor as LH, but its secretion is
not subject to the same negative feedback by steroids
as are the pituitary gonadotropins. Geometrically in-
creasing quantities ofhCG are required for luteal main-
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FIGURE 2. Compartmental luteal steroidogenesis.
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tenance, consistent with the pattern ofthe rise in hCG
observed in early pregnancy. The corpus luteum hy-
pertrophies in early pregnancy, and clinical ovarian en-
largement is common. By 8 to 10 weeks of gestation,
the trophoblast has assumed the role as the primary
producer of steroids, and the corpus luteum regresses.
Throughout the remainder of pregnancy, the ovary is
hormonally inactive, as the gonadotropins are sup-
pressed by the high concentrations of circulating ste-
roids.
Gonadotropin suppression, while preventing ovula-
tion, does not prevent follicle loss through atresia. Fol-
licles continue to mature independent ofthe gonadotro-
pins, but without sufficient gonadotropins during the
critical interval of gonadotropin sensitivity, atresia
inevitably results. Consequently, the reproductive life-
span is not lengthened by the use ofagents such as oral
contraceptives that act to suppress the pituitary's re-
lease of gonadotropins.
As women enter the latter stages of their reproduc-
tive years, the steroid production by morphologically
normal follicles declines. Simultaneously, FSH levels
gradually rise, most prominently in the early follicular
phase. It is unclear whether this is due to intrinsically
unhealthy follicles that have not matured throughout
the reproductive years or anecessity for alarge number
offollicles to be present. Eventually, a point is reached
at which anovulatory cycles predominate, and atresia
prior to ovulation is the rule. Estrogen without the op-
position of progesterone predominates, and peripheral
target organs are constantly exposed to estrogen. This
climacteric interval covers the approximately 8 to 10
year span ofdeclining ovarian function. As the estrogen
levels decrease, eventually a point is reached at which
menstruation ceases. The date ofthe last menstruation
is termed the menopause, but represents only a highly
identifiable clinical marker ofthe climacteric. After the
climacteric, only stromal estrogen production remains
and this is insufficient to maintain the peripheral estro-
gen target organs, resulting in clinical symptoms ofhy-
poestrogenism, i.e., atrophic vaginitis, vasomotor hot
flushes, etc. (Plate 4). Follicles can still be observed
occasionally after the menopause in the ovarian stroma,
but their functional capabilities are obviously limited.
Clinical Syndromes of Ovarian
Dysfunction
Premature Ovarian Failure
As women possess a fixed number ofoocytes at birth,
all women eventually undergo ovarian failure if their
life-span exceeds the number of years during which fol-
licles continue to be present. The mean age of meno-
pause has been remarkably constant throughout re-
corded history regardless of the population studied,
averaging approximately 50 years. Premature loss of
oocytes results in morphologic and functional gonadal
failure at a chronologically inappropriate time. Despite
the high levels ofgonadotropins circulating at this time,
the steroid productionbythe ovarian stromais low, and
no obvious hypertrophy of the ovarian stroma is ob-
served. Avariety ofdisease states havebeen associated
with ovarian failure, as listed in Table 2.
The category ofthe "resistant ovary" is one in which
histologically normal follicular structures are present,
but apparently they are unresponsive to the circulating
gonadotropins. This could be related to either defective
gonadotropin synthesis or absent/nonfunctional ovarian
gonadotropin receptors. In patients with an autoim-
mune basis for ovarian failure, an inflammatory process
is usually present in the ovary. In all other circumstan-
ces of premature ovarian failure, the ovaries are mor-
phologically indistinguishable from those of normal
postmenopausal women (Plate 4).
Polycystic Ovary Syndrome
A unique syndrome of anovulation was identified in
the 1930s and termed polycystic ovary syndrome. In
this disease, multiple atretic follicles with active-ap-
pearingthecal compartments are presentjustunderthe
ovarian capsule. The capsule itselfis thickened and the
ovarian stromal compartment is increased in size. The
syndrome is clinically manifested by altered levels of
circulating gonadotropins with an elevated LH to FSH
ratio (greater than 3 versus a normal ratio of 1), hy-
perandrogenism manifested by elevated testosterone
and androstenedione, and chronic unopposed estrogen
effects on target organs. While this was originally
thought to represent a single syndrome, it is now ap-
parentthatthere aremultiple subgroups, indistinguish-
able on clinical criteria. The morphology of the ovary
in polycystic ovary syndrome appears to be a conse-
quence ofthe anovulation with alarge numberofatretic
follicles rather than any specific characteristic of the
disease. Consequently, anything which alters gonado-
tropin levels and impedes follicular development results
in this clinical syndrome.
The hypothalamic-pituitary axis in women with po-
lycystic ovary syndrome is intact with operative neg-
ative and positive gonadotropin feedback function. The
Table 2. Causes of ovarian failure.
Cause Description
Idiopathic
Chromosomal abnormalities
Iatrogenic Surgery
Chemotherapy
Radiation therapy
Autoimmune oophoritis Primary in ovary
Associated with other autoim-
mune endocrine diseases
Viral oophoritis
Resistant ovary syndrome Primordial follicles present in the
ovary
Congenital absence of the thymus
17-Hydroxylase deficiency
Galactosemia
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aberrant gonadotropin profiles can be mimicked by ex-
cess androgen, whatever the source. Women with an-
drogen-secreting tumors have been identified to have a
histologic pattern consistent with polycystic ovary syn-
drome in the contralateral ovary. When their tumors
are removed and their circulating androgens decline,
the ovary reverts to normal both morphologically and
functionally. A primary ovarian defect in polycystic
ovary syndrome has also been postulated based on al-
tered gonadotropin responsiveness. Theoretically, this
could be due to an alteration in gonadotropin binding
or inappropriate production of gonadotropin receptor
regulatory proteins.
Compartmentalized ovarian hormone secretion has
recentlybeeninvestigated. It appearsthatinpolycystic
ovary syndrome, the ovarian androgens are produced
primarily from the theca, and the large amounts ofan-
drogens are attributable to the large number ofatretic
follicles. During the atretic process, estrogen produc-
tion by the granulosa cell compartment declines, but
androgen and estrogen production bythe thecais main-
tained. This results in the seemingly paradoxical situ-
ation of simultaneous androgen excess and chronic un-
opposed estrogen.
Despite the inability to ovulate, a follicular response
to gonadotropins is still present. Treatment with both
clomiphene citrate, whose action is mediated through
the hypothalamus, and human menopausal gonadotro-
pins, which act directly onthe ovary, result in follicular
development and ovulation. With the use ofclomiphene
citrate, thepositive feedback effect ofestrogentriggers
the midcycle gonadotropin surge, whereas with exog-
enous gonadotropins, the spontaneous surge will not
occur and hCG is used as a surrogate LH surge.
Isolated luteinized cells are observed scattered
throughout the ovarian stroma in polycystic ovary syn-
drome. The term "luteinized cells" simply describes
lipid-containingcellsconsistentmorphologicallywithac-
tive steroidogenesis. Whether these are stromal cells
responding to the altered gonadotropins or are rem-
nants of the theca of previously atretic follicles is un-
known.
Hyperthecosis
Hyperthecosis is a syndrome similar in clinical pre-
sentation to polycystic ovary syndrome, but the andro-
genizationismore severe. Whilethecirculatinggonado-
tropin levels are similar, the testosterone concentra-
tions are significantly higher, often overlapping the
range usually seen with androgen-secreting ovarian tu-
mors.
Theterm "hyperthecosis" isusedbecause ofthelarge
number of steroidogenically active cells present in the
ovarian stroma (Plate 5). These cells are indistinguish-
able in appearance from the luteinized cells present in
the stroma of polycystic ovarian patients, except the
number of cells is greater constituting large areas of
the ovarian stroma. Reminiscent of the confusion with
polycystic ovary syndrome, it is unclear whether these
represent remnants of previous thecal compartments
from follicles that have previously undergone atresia or
are aunique thecalorstromalresponse. Similarly, their
gonadotropin dependence is not known. The ovary is
typically not as large as in polycystic ovary syndrome,
as there is a smaller complement of atretic follicles.
Consistent with that observation, it is much more dif-
ficult to stimulate ovulation in these women.
Stromal Activation by Ovarian Tumors
The association ofendocrinologically inert ovariantu-
mors with clinical signs of sex steroid production has
frequently been observed. Often, lipid-laden stromal
cells are noted adjacent to the tumors in the remaining
nontumorous ovarian stroma. These morphological
changes have suggested activation ofthese surrounding
stromal cells, with the observed clinical hormone pro-
duction attributed to this presumed stromal steroido-
genesis. Virtuallyanyhistologictumortypecanbepres-
ent, including primary or metastatic ovarian cancer.
Because ofthe difficulty in mechanically isolating these
stromal cells, steroid production has never been exper-
imentally verified but is likely on histologic criteria
alone. The mechanism of this activation is unknown.
Endocrinologically Active Ovarian Tumors
Whenneoplastic, thegonadalstromacandifferentiate
alongeithermale orfemalelines (Table3). Thisincludes
Leydigand Sertolicellsthatmimicmale differentiation,
and granulosa and thecal cells that yield female differ-
entiation. It is not clear whether these represent anal-
ogous processes, as the granulosa and thecal cells are
normally present within the ovary. Either one or both
cell types in each category can be present, and rarely,
both male and female cell types will be present in the
same tumor (Plate 6). Although the majority of these
tumors are benign, they can occasionally be malignant.
Their major clinical importance is the peripheral con-
sequences on the sex hormone target organs. Marked
Table 3. Classification of endocrinologically active ovarian
tumors.
Result
Female differentiation
Male differentiation
Male and female differentiation
Other
Tumor type
Granulosa cell
Thecoma
Granulosa/theca cell
Leydig cell
Sertoli cell
Sertoli/Leydig cell (arrhenoblas-
toma)
Gynandroblastoma
Gonadoblastoma
(germ cell tumor with stromal
elements)
Lipoid cell
Hilus cell
Clear cell (adrenal rest cell tu-
mor)
Luteoma ofpregnancy
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virilization can be observed withandrogen-secreting tu-
mors, while endometrial adenocarcinomas are common
when estrogen-secreting tumors are present after men-
opause.
Any ofthese tumors can produce either androgens or
estrogens, and the clinical presentation will reflect the
particular steroid or steroids secreted. Those that dif-
ferentiate along male lines tend to be androgen-secret-
ing tumors, and those that differentiate along female
lines tend to be estrogen-secreting tumors. Occasion-
ally, both androgens and estrogens are secreted, and
the women are simultaneously androgenized and estro-
genized. A unique histologic marker for androgen pro-
duction, regardless ofthe tumor cell type, is the intra-
cellular crystaloid of Reinke.
The luteoma is an ovarian tumor, usually masculin-
izing, which is found only in pregnancy. It is typically
yellow in color and histologically is composed of sheets
oflipid-laden cells resembling a corpus luteum. It is not
clear whether this is a true neoplasm or simply repre-
sents an exaggerated physiologic response ofthe ovar-
ian stroma to hCG. Whether development of all these
tumors is dependent on gonadotropins is unknown. As
they generally respond with increased hormone output
when given hCG, a relationship to gonadotropin stim-
ulation remains an intriguing possibility.
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PLATE 1. The follicle wall of an atretic follicle. The pyknotic granulosa cell layers characteristic of an atretic follicle are present, overlying
relativelyactive-appearingtheca. Theindividual thecalcells still appearsteroidogenically active, consistentwiththemaintenanceofhormone
production by the atretic theca. H&E, x 400.
PLATE 2. An early antral follicle. A developing antral follicle is present with coalescing pools offollicular fluid. The oocyte is not in the plane
of section and the number of granulosa cell layers is small. The theca is not yet prominent but is distinguishable from the surrounding
ovarian stroma. H&E, x 400.
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PLATE 3. Thecorpusluteum. Aportionofacorpusluteumispresent
surroundedbytypicalovarian stromawiththecapsuleoftheovary
at the top of the picture. The distinction between the luteinized
granulosa and theca layers is difficult, as the granulosa compart-
ment becomes vascularized rapidly after ovulation. The individual
luteal cells have the characteristics of steroidogenically active
cells, with large, clear areas in the cytoplasm representing lipid
accumulations. H&E, x 130.
PLATE 4. The postmenopausal ovary. A single layer ofgerminal epithelium covers the ovarian capsule with typical ovarian stroma devoid of
follicles. H&E, x 250.
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PLATE 5. Ovarian hyperthecosis. The ovarian stroma of an androgenized woman with chronic anovulation demonstrates an area of steroi-
dogenically active-appearing cellsconsistent with excessive androgen production. These luteinized cells are scattered throughout the normal
ovarian stroma. H&E, x 250.
PLATE 6. Gonadoblastoma. A typical steroidogenically active gonadoblastoma is shown with both granulosa cell elements on the left side and
attempts at seminiferous tubule formation on the right. Areas of apparent follicular fluid fornation (Call-Exner bodies) are present in the
granulosa cell elements (-*) typical ofnormal granulosa cells. H&E, x 250.
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